Evidence map›Paper›PMID 19570712›Full record

ReviewCurrent opinion in pharmacology2009

HLA-G: a human pregnancy-related immunomodulator.

Joan S Hunt, Daudi L Langat

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 92 citations in OpenAlex.

  1. Immunology of Pregnancy and Systemic Consequences.Current topics in microbiology and immunology · 2023
    Article
  2. Article
  3. Review
  4. Article
  5. Unique Aspects of Human Placentation.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Innate immunity, decidual cells, and preeclampsia.Reproductive sciences (Thousand Oaks, Calif.) · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Joan S HuntDepartment of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS, United States. jhunt@kumc.edu
Daudi L Langat
University of Kansas Medical Center · US

Funding

TISSUE PROCUREMENT AND GENOTYPING COREP01HD049480 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI OBER, CAROLE · 2007 to 2011
$4.9M
DECIDUAL CELL/PLACENTAL INTERACTIONSR01HD024212 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HUNT, JOAN SHERAR · 1994 to 2007
$1.7M
DECIDUAL CELL/PLACENTAL INTERACTIONSR29HD024212 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HUNT, JOAN SHERAR · 1989 to 1993
–
NICHD NIH HHS HD04940NICHD NIH HHS HD24212NICHD NIH HHS P01 HD049480NICHD NIH HHS R01 HD024212
6 · The paper itself

Abstract

In human pregnancies mothers and their embryo/fetuses are invariably genetically different. Thus, attenuation of the adaptive maternal immune response, which is programmed to reject 'foreign' entities, is required for pregnancy to be initiated and maintained. Unexpectedly, given the propensity of the immune system to dispose of non-self entities, at least 50% of expected human pregnancies reliably go forward. This indicates that to a large extent, effective systems of tolerance have evolved. Although overlapping and redundant mechanisms of tolerance have been identified, production of HLA-G by trophoblast cells derived from the external trophectoderm layer of the blastocyst appears to be of major importance. At this point in time, no pregnancies in which all of the proteins derived from the HLA-G gene are absent have as yet been reported. Many studies have shown that both membrane-bound and soluble isoforms of the proteins derived from this HLA class Ib gene are produced by placental trophoblast cells, with consequences that include but are not restricted to immune suppression at the maternal-fetal interface. Here we report new studies that are leading to a better understanding of the HLA-G proteins, their unique structures, unusual modes of regulation, diverse functions, and potential for use in diagnostic and therapeutic procedures related to suboptimal fertility in women.

Indexed as

BiomarkersFemaleFertilityHistocompatibility Antigens Class IHLA AntigensHLA-G AntigensHumansImmunologic FactorsMaternal-Fetal ExchangePregnancyBiomarkersHistocompatibility Antigens Class IHLA AntigensHLA-G AntigensImmunologic Factors

Identifiers

PMID19570712
PMCPMC2747610
OpenAlexW2026125052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.